分裂设计方法增强了基于连接体的CAR-T细胞对多种B细胞恶性瘤的治疗疗效

Shuhong Li1, Licai Shi1, Lijun Zhao1

  • 1State Key Laboratory of Chemical Oncogenomics, Shenzhen Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong, China.

Nature communications
|November 11, 2024
PubMed
概括

这项研究引入了一种新型的分裂嵌合抗原受体 (CAR) -T细胞策略,使用天然配体来防止癌症治疗中的免疫逃逸. 这种方法提高了B细胞恶性瘤的CAR-T细胞疗效和安全性.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K